Experience of Novelty Laser Therapy Emission with 675 nm Wavelength for the Treatment of Androgenetic Alopecia in Male and Female Patients: A Case Series Study

    Elisabetta Sorbellini, Irene Fusco, Francesca Madeddu, Michela Libra
    Image of study
    TLDR The 675 nm laser treatment significantly increased hair density and reduced symptoms of androgenetic alopecia in both men and women, with no side effects.
    The study assessed the efficacy of a 675 nm laser treatment for managing androgenetic alopecia in 17 subjects (6 women and 11 men) aged 18 to 65 years. The subjects, who had alopecia grades ranging from I-II in women and I-II-III in men, underwent 10 sessions of the laser treatment, each lasting 20 minutes. The results, verified at the third month of follow-up and at the end of treatment, showed a significant increase in hair shaft density and a reduction of yellow dots and telangiectasias characteristic of androgenetic alopecia. The 675 nm laser treatment resulted in a 60% reduction of the miniaturization process in the treated areas, with no side effects reported.
    Discuss this study in the Community →

    Research cited in this study

    15 / 15 results

    Related Community Posts Join

    4 / 4 results
      PP405 Identity Research

      community PP405 Identity Research

      in Research  292 upvotes 1 week ago
      PP405 is a potential hair loss treatment that inhibits mitochondrial pyruvate carriers, increasing lactate dehydrogenase activity and stimulating hair follicle stem cells. In a phase 1 trial, 31% of participants showed over 20% hair density increase with PP405 treatment.
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      in Research  830 upvotes 1 year ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

    Related Research

    1 / 1 results